IN2012DN00486A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00486A
IN2012DN00486A IN486DEN2012A IN2012DN00486A IN 2012DN00486 A IN2012DN00486 A IN 2012DN00486A IN 486DEN2012 A IN486DEN2012 A IN 486DEN2012A IN 2012DN00486 A IN2012DN00486 A IN 2012DN00486A
Authority
IN
India
Prior art keywords
attenuate
exercise
loss
nutritional
functional status
Prior art date
Application number
Other languages
English (en)
Inventor
Kevin Burke Miller
Ingo Arne Jurk
Zamzam Fariba Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00486A publication Critical patent/IN2012DN00486A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
IN486DEN2012 2009-07-20 2010-07-15 IN2012DN00486A (enrdf_load_stackoverflow)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22680609P 2009-07-20 2009-07-20
US33424710P 2010-05-13 2010-05-13
PCT/US2010/042083 WO2011011252A1 (en) 2009-07-20 2010-07-15 Methods of attenuating the loss of functional status

Publications (1)

Publication Number Publication Date
IN2012DN00486A true IN2012DN00486A (enrdf_load_stackoverflow) 2015-05-22

Family

ID=42990259

Family Applications (1)

Application Number Title Priority Date Filing Date
IN486DEN2012 IN2012DN00486A (enrdf_load_stackoverflow) 2009-07-20 2010-07-15

Country Status (13)

Country Link
US (1) US20120195873A1 (enrdf_load_stackoverflow)
EP (2) EP2456448A1 (enrdf_load_stackoverflow)
JP (1) JP2012533627A (enrdf_load_stackoverflow)
CN (1) CN102647990A (enrdf_load_stackoverflow)
AU (1) AU2010274125B2 (enrdf_load_stackoverflow)
BR (1) BR112012001488A2 (enrdf_load_stackoverflow)
CA (1) CA2768471A1 (enrdf_load_stackoverflow)
IN (1) IN2012DN00486A (enrdf_load_stackoverflow)
MX (1) MX2012000943A (enrdf_load_stackoverflow)
RU (1) RU2012105901A (enrdf_load_stackoverflow)
SG (1) SG177664A1 (enrdf_load_stackoverflow)
WO (1) WO2011011252A1 (enrdf_load_stackoverflow)
ZA (1) ZA201201229B (enrdf_load_stackoverflow)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102917604B (zh) * 2010-03-12 2015-01-07 雀巢产品技术援助有限公司 掩蔽营养素味道的组合物及其制备方法
WO2011139621A1 (en) * 2010-04-26 2011-11-10 Nestec S.A. Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
JP2014507437A (ja) * 2011-02-25 2014-03-27 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 関節及び／又は体位の安定性を高める組成物
RU2013151090A (ru) * 2011-04-18 2015-05-27 Нестек С.А. Питательные композиции, содержащие альфа-гидроксиизокапроновую кислоту и эйкозапентаеновую кислоту
SG194918A1 (en) * 2011-06-08 2013-12-30 Nestec Sa Nutritional compositions having exogenous milk fat globule membrane components
JP2013051920A (ja) * 2011-09-05 2013-03-21 Ishikawa Prefectural Public Univ Corp 骨密度強化補助食品
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
EP2583565A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for enhancing energy expenditure and satiety
PL2583566T3 (pl) * 2011-10-21 2016-01-29 Nestec Sa Micele serwatkowego białka do zwiększania masy mięśni i sprawności
EP2583563A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
WO2013102873A2 (en) * 2012-01-03 2013-07-11 Nestec S.A. Compositions and methods for the stability of reactive amino acids in a food matrix
RU2520036C2 (ru) * 2012-03-01 2014-06-20 Общество с ограниченной ответственностью "Институт новых технологий" Пищевой продукт "миоактив-спорт" для питания людей, подверженных интенсивным физическим нагрузкам
JP2015532104A (ja) 2012-10-04 2015-11-09 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 骨格筋減少の緩和に対するｅｇｃｇの効果を増強するための方法
CN103783532B (zh) * 2012-10-29 2016-06-08 杭州纽曲星生物科技有限公司 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法
CN103271350B (zh) * 2013-03-04 2014-09-24 中国航天员科研训练中心 空间站航天员太空高能压缩食品及其制法
MX2015012821A (es) 2013-03-14 2016-05-31 Abbott Lab Tratamiento de resistencia a la insulina asociado con la inactividad fisica prolongada.
JP2016517438A (ja) 2013-03-15 2016-06-16 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 筋肉機能を維持し、改善する方法
ES2617714T5 (es) * 2013-04-15 2021-02-11 Nestle Sa Empleo de la proteína de suero en combinación con la estimulación eléctrica muscular
SG11201508388YA (en) * 2013-05-01 2015-11-27 Abbott Lab Methods for enhancing aged muscle regeneration
WO2014191856A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
AU2013392167B2 (en) 2013-06-10 2017-04-27 N.V. Nutricia Muscle preservation in overweight or obese adult during weight loss program
JP6279851B2 (ja) * 2013-07-19 2018-02-14 雪印メグミルク株式会社 筋萎縮防止及び／又は筋合成促進剤
JP6811170B2 (ja) * 2014-07-21 2021-01-13 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 安全な嚥下を促進する嚥下障害者用栄養製品
DK3006027T3 (en) * 2014-10-08 2017-12-18 Professional Dietetics Spa Compositions comprising amino acids for use in the treatment of systemic inflammation associated with stroke in dysphagia patients
CA2963182C (en) * 2014-10-14 2023-10-17 Nestec S.A. Improvement in muscle functionality of elderly males
TR201908045T4 (tr) * 2014-11-19 2019-06-21 Nestec Sa Peynir Altı Suyu Protein Miselleri Ve Pektin Karışımının Vücut Ağırlığını Kontrol Amaçlı Kullanımı.
EP3377077A1 (en) * 2015-11-20 2018-09-26 Nestec S.A. Methods using whey protein to improve or maintain muscle quality
SG11201804602SA (en) * 2015-12-03 2018-06-28 Meiji Co Ltd Nutritional composition
AU2016375964A1 (en) 2015-12-22 2018-05-17 Société des Produits Nestlé S.A. Methods for treating sarcopenia and frailty
TW201808120A (zh) * 2016-03-16 2018-03-16 味之素股份有限公司 行動體力提升劑
AU2016402338A1 (en) * 2016-04-14 2018-11-08 Michael LUCEY Combinational compositions and methods of use thereof
JP6948103B2 (ja) * 2016-04-14 2021-10-13 株式会社明治 フレイル改善用組み合わせ物
CN109152749A (zh) * 2016-05-27 2019-01-04 雀巢产品技术援助有限公司 用于治疗或预防移动性受损的营养组合物
BR112019009757B1 (pt) * 2016-11-16 2022-12-20 Fresenius Kabi Deutschland Gmbh Pufa, vitamina e, vitamina d e os aminoácidos ligados às proteínas glicina, arginina e triptofano, seu uso na fabricação de uma composição nutricional para tratar sarcopenia e/ou fraqueza e composição nutricional
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11504413B2 (en) 2017-03-03 2022-11-22 Exerkine Corporation Multi-nutrient composition
WO2018221526A1 (ja) * 2017-06-01 2018-12-06 株式会社明治 栄養組成物
TWI775921B (zh) 2017-08-14 2022-09-01 美商胺細拉健康公司 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
JP7044306B2 (ja) * 2018-07-31 2022-03-30 ユーハ味覚糖株式会社 ロイシン血中濃度上昇促進剤及びその用途
WO2020120224A1 (en) * 2018-12-13 2020-06-18 Société des Produits Nestlé S.A. Liquid concentrates formulated for dilution into nutritional products to promote safe swallowing for individuals with dysphagia
HRP20230743T1 (hr) 2019-06-28 2023-10-27 Dompé Farmaceutici Spa Nova kompozicija koja sadrži aminokiseline razgranatog lanca
WO2021079987A1 (ja) * 2019-10-25 2021-04-29 味の素株式会社 筋質向上剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
CN1101810A (zh) * 1994-08-23 1995-04-26 谢宝兴 茯苓枸杞子口服液饮料袋泡茶及其生产方法
EP1062876A1 (en) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caseinoglycomacropeptides as calcification agent
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US7794770B2 (en) * 2004-10-07 2010-09-14 Next Proteins, Inc. Protein beverage and method of making the same
US20060198899A1 (en) * 2005-03-01 2006-09-07 Gardiner Paul T Supplemental dietary composition for supporting muscle growth, recovery and strength
FR2882896B1 (fr) * 2005-03-14 2007-05-04 Larena Sa Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
NZ566691A (en) * 2005-09-09 2011-06-30 Murray Goulburn Coop Co Ltd Composition of whey growth factor extract for reducing muscle inflammation
DE602006019941D1 (de) * 2006-03-27 2011-03-17 Nestec Sa Im Proteingehalt angereichertes gefrorenes Dessert
EP1839504B2 (en) * 2006-03-27 2015-02-18 Nestec S.A. In situ preperation of whey protein micelles
CA2666871C (en) * 2006-10-19 2011-08-30 Nestec S.A. Long term feed - cancer patient
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.
EP2288268A1 (en) * 2008-05-21 2011-03-02 Stokely-Van Camp, Inc. Milk-based recovery beverage
WO2010002242A1 (en) * 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity

Also Published As

Publication number Publication date
SG177664A1 (en) 2012-02-28
MX2012000943A (es) 2012-02-28
RU2012105901A (ru) 2013-08-27
BR112012001488A2 (pt) 2019-10-08
JP2012533627A (ja) 2012-12-27
EP2456448A1 (en) 2012-05-30
AU2010274125A1 (en) 2012-02-16
AU2010274125B2 (en) 2015-11-05
CA2768471A1 (en) 2011-01-27
CN102647990A (zh) 2012-08-22
US20120195873A1 (en) 2012-08-02
EP3231435A1 (en) 2017-10-18
WO2011011252A1 (en) 2011-01-27
ZA201201229B (en) 2013-07-31

Similar Documents

Publication Publication Date Title
IN2012DN00486A (enrdf_load_stackoverflow)
ZA201103584B (en) Whey protein compositions,methods and uses
IN2015DN02826A (enrdf_load_stackoverflow)
PH12012500740A1 (en) Nutritional compositions including a high protein component and exogenous nucleotides
GEP201706733B (en) Anti-il-23 antibodies
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
PH12015500636A1 (en) Nutritional compositions including a calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
ZA201300690B (en) Hypocaloric,high protein nutritional compositions and methods of using same
IN2014CN02970A (enrdf_load_stackoverflow)
HK1199378A1 (en) Compositions and methods for use in promoting lean body mass
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
WO2011019641A3 (en) Nutritional compositions including exogenous nucleotides
PH12013500917A1 (en) Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
MY155615A (en) Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
MX2010008280A (es) Composicion para estimular la actividad de celula asesina natural.
PH12015500049B1 (en) Novel protein material
BRPI1015300A8 (pt) "composição nutricional compreendendo um extrato de maçã e reduzindo os sintomas de alergia a alimentos, especialmente em crianças"
MX342306B (es) Composicion de chocolate aireada.
WO2011037712A3 (en) Nutritional compositions including theanine and exogenous nucleotides
PH12014500914A1 (en) Dietary supplement for vascular health
WO2012036414A3 (ko) 발효콩 추출 분획물을 유효 성분으로 포함하는 화장료 조성물
PL2535047T3 (pl) Kompozycja odżywcza, suplement diety zawierający kompozycję odżywczą i zestaw zawierający suplement diety
WO2012081893A3 (ko) 신규한 3-인돌리논 유도체 및 이를 포함하는 조성물
WO2012119049A3 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease